Somatoform Disorders: Clinical Trials

9 trials for Somatoform Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 9
Phase 21Completed 1

Follow Somatoform Disorders: new trials by email Literature Review of Somatoform Disorders trials Research Report on Somatoform Disorders

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
Ranquilon, Placebo - Anxiety, Neurasthenia
Phase 3CompletedValenta Pharm JSC2202022-10-122023-07-27
Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles
Botulinum toxin type A, 0.9% Sodium Chloride Injection - Pain, Head, Pain Syndrome
Phase 3CompletedWeill Medical College of Cornell University752018-08-312023-02-14
Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors
Omeprazole, psychoeducation, Flupentixol +Melitracen - Globus
Phase 3CompletedMahidol University402017-07-072018-08-22
Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis
Psychotherapy (CT or ET) - Hypochondriasis, Somatoform Disorders
Phase 3CompletedGoethe University842010-06-012014-08-06
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
Escitalopram, Placebo - Anxiety Disorders, Somatoform Disorders
Phase 3CompletedMassachusetts General Hospital1002005-05-012017-12-05
Integrated Treatment Program for Hypochondriasis in Primary Care Settings
Relaxation response training, Psychoeducational counseling - Hypochondriasis, Somatoform Disorders
Phase 3CompletedBrigham and Women's Hospital912005-05-012013-03-19
Treatment of Patients With Longstanding Unexplained Health Complaints
Cognitive Behavioral Therapy, Recommendation of care (letter to general practitioner [GP]) - Somatization Disorder
Phase 2 / Phase 3CompletedUniversity of Aarhus1202005-04-012011-11-16
Treatment of Medically Unexplained Physical Ailments (Somatization Disorder)
Cognitive Behavioral Therapy, CBT - Somatoform Disorders
Phase 3CompletedUniversity of Medicine and Dentistry of New Jersey1722001-02-012014-01-14
DEPENAS: A Psychosocial Intervention for Patients With Medically Unexplained Symptoms
DEPENAS cognitive and behavioural techniques - Somatoform Disorders
Phase 3CompletedBasque Health Service1562001-01-012008-07-15

Narrower conditions

Anxiety Disorders (2)  ·  Hypochondriasis (2)  ·  Medically Unexplained Symptoms (2)  ·  Adjustment Disorders (1)  ·  Body Dysmorphic Disorders (1)  ·  Globus Sensation (1)  ·  Headache (1)  ·  Myofascial Pain Syndromes (1)  ·  Neurasthenia (1)  ·  Temporomandibular Joint Disorders (1)

Broader conditions

Mental Disorders (9)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Conversion Disorder (1)  ·  Craniomandibular Disorders (1)  ·  Jaw Diseases (1)  ·  Joint Diseases (1)  ·  Mandibular Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Stomatognathic Diseases (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Cognitive Behavioral Therapy (3)  ·  Botulinum Toxins, Type A (1)  ·  Counseling (1)  ·  Escitalopram (1)  ·  GB-115 (1)  ·  Idoxuridine (1)  ·  Implosive Therapy (1)  ·  Omeprazole (1)  ·  Palliative Care (1)  ·  Psychotherapy (1)  ·  Sodium Chloride (1)  ·  flupentixol, melitracen drug combination (1)

Sponsors

Basque Health Service (1)  ·  Brigham and Women's Hospital (1)  ·  Goethe University (1)  ·  Mahidol University (1)  ·  Massachusetts General Hospital (1)  ·  University of Aarhus (1)  ·  University of Medicine and Dentistry of New Jersey (1)  ·  Valenta Pharm JSC (1)  ·  Weill Medical College of Cornell University (1)

Countries

United States (4)  ·  Denmark (1)  ·  Germany (1)  ·  Russia (1)  ·  Thailand (1)

Top investigators

Arthrur J. Barsky, MD (1)  ·  Florian Weck, PhD (1)  ·  Gwendolyn S Reeve, DMD (1)  ·  Javier I Escobar, M.D. (1)  ·  Jose M Aiarzaguena, Dr. (1)  ·  Katharine Phillips, MD (1)  ·  Michael A Gara, Ph.D. (1)  ·  Michael Miloro, DMD (1)  ·  Monthira Maneerattanaporn, MD., MS. (1)  ·  Per Fink, Dr.Med.Sc. (1)  ·  Sabine Wilhelm, PhD (1)

Results publications

PMID 19930729, PMID 22539780, PMID 23494213, PMID 29557815, PMID 31505519, PMID 38228287

NIH funding

R01MH040487 (1), R01MH060265 (1), R01MH072854 (1)